Jonathan A Fletcher

Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases

Heikki Joensuu, Richard Herrmann, J. Fletcher, 2008, Clinical Cancer Research.

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

Rob Pieters, Todd R Golub, John H Kersey, 2003, Cancer cell.

Targeted Therapy in Breast Cancer

Lajos Pusztai, K. Bloom, J. Stec, 2004, Molecular & Cellular Proteomics.

Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles

Tina Hernandez-Boussard, Kelli Montgomery, Matt van de Rijn, 2004, Oncogene.

Biology of Gastrointestinal Stromal Tumors: KIT Mutations and Beyond

J. Fletcher, M. Heinrich, C. Fletcher, 2004, Cancer investigation.

Genomic and functional evidence for an ARID1A tumor suppressor role

Yu Li, Y. Li, J. Fletcher, 2007, Genes, chromosomes & cancer.